ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.

William D Tap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.